16-284575-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006849.4(PDIA2):c.388C>T(p.His130Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 1,612,292 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDIA2 | NM_006849.4 | c.388C>T | p.His130Tyr | missense_variant | 2/11 | ENST00000219406.11 | NP_006840.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDIA2 | ENST00000219406.11 | c.388C>T | p.His130Tyr | missense_variant | 2/11 | 1 | NM_006849.4 | ENSP00000219406.7 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000494 AC: 121AN: 244916Hom.: 1 AF XY: 0.000442 AC XY: 59AN XY: 133444
GnomAD4 exome AF: 0.000258 AC: 377AN: 1460062Hom.: 1 Cov.: 31 AF XY: 0.000253 AC XY: 184AN XY: 726304
GnomAD4 genome AF: 0.000289 AC: 44AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000296 AC XY: 22AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2021 | The c.388C>T (p.H130Y) alteration is located in exon 2 (coding exon 2) of the PDIA2 gene. This alteration results from a C to T substitution at nucleotide position 388, causing the histidine (H) at amino acid position 130 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at